Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30354-9/fulltext
https://www.neurologyadvisor.com/topics/multiple-sclerosis/the-role-of-ketamine-infusion-for-patients-with-ms-related-fatigue/
Primary outcome of the study was negative.
Reference
Fitzgerald KC, Morris B, Soroosh A, et al. Pilot randomized active-placebo-controlled trial of low-dose ketamine...
Full title: Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration
Open access, https://www.metabolismjournal.com/article/S0026-0495(17)30217-2/fulltext
Note: The term "chronic fatigue syndrome" is used often in this paper. As far as I can see the authors actually mean "chronic fatigue", which is why I have opened this thread in the "Health News and Research unrelated to ME/CFS" sub-forum, not elsewhere.
Open access...
https://nn.neurology.org/content/7/5/e854
Popular article here
Hunting for a "Hidden Pathology": Why Is Fatigue So Debilitating in Multiple Sclerosis?
https://www.technologynetworks.com/neuroscience/news/hunting-for-a-hidden-pathology-why-is-fatigue-so-debilitating-in-multiple-sclerosis-339120
Full title: A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Open access, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842501/
Popular article
https://multiplesclerosisnewstoday.com/news-posts/2020/07/07/pilot-randomized-active-placebo-controlled-trial-of-low-dose-ketamine-for-the-treatment-of-multiple-sclerosisrelated-fatigue/
Journal
https://journals.sagepub.com/doi/abs/10.1177/1352458520936226?journalCode=msja
https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-01810-8
https://multiplesclerosisnewstoday.com/blood-factors-impair-metabolism-blood-brain-barrier-ms-study/
I thought this could be of interest, since one of Jarred Younger's upcoming studies is testing the hypothesis...
https://link.springer.com/article/10.1007/s10286-020-00676-3
Autonomic dysfunction, namely gastrointestinal, genitourinary, and cardiovascular abnormalities, is a key feature of the prodromal phase of other neurological disorders, such as Parkinson disease and other synucleinopathies [6]...
How and for whom does supportive adjustment to multiple sclerosis cognitive-behavioural therapy work? A mediated moderation analysis
KimberleyGoldsmitha1Joanna L.Hudsonb1TrudieChaldercLauraDennisondRona MossMorrisb
https://www.sciencedirect.com/science/article/abs/pii/S0005796720300450...
I thought this piece of (oldish) research might be of interest to people interested in measuring cognitive dysfunction in ME. It notes that self reported fatigue in MS doesn't correlate well with actual cognitive performance measures (which is the same in ME). Here, they developed a new...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.